Skip to content
2000
Volume 32, Issue 32
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Introduction

The incidence of Breast Cancer (BC), a prevalent malignancy in women, has gone up recently, although the molecular pathways underlying the carcinogenesis of BC are still unknown. Long non-coding RNAs (lncRNAs) have become important tumor progression regulators.

Methods

The present study has revealed increased expression of LINC00651 in BC tissues through a thorough investigation of whole-transcriptome resequencing on matched BC and normal tissues from 8 patients. It is yet unknown precisely as to what biological function LINC00651 serves in BC.

To obtain further insight, 39 matched pairs of breast tumors and normal tissues underwent Real-time quantitative Polymerase Chain Reaction (RT-qPCR) for validation. The validated cohort's clinicopathologic characteristics were then carefully examined. Following short interfering RNA transfection, proliferation, colony formation, migration, invasion, and examination of phenotypes associated with the Epithelial-mesenchymal Transition (EMT) were conducted in BC cell lines (MDA-MB-231 and BT-549).

Results

Our findings have confirmed that LINC00651 plays a role in augmenting BC cell lines' proliferation, migration, and invasion. Consequently, LINC00651 can be considered a potential new therapeutic target for BC treatment.

Conclusion

As breast cancer remains a significant health concern, understanding its molecular underpinnings is crucial for developing effective treatments. The identification of LINC00651 as a promoter of BC cell growth and metastasis has suggested that it could be a promising target for future therapeutic interventions, potentially offering new avenues for improved patient outcomes.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673328556240813111417
2024-08-21
2025-10-26
Loading full text...

Full text loading...

References

  1. SiegelR.L. MillerK.D. JemalA. Cancer statistics, 2018.CA Cancer J. Clin.201868173010.3322/caac.2144229313949
    [Google Scholar]
  2. ChenW. ZhengR. BaadeP.D. ZhangS. ZengH. BrayF. JemalA. YuX.Q. HeJ. Cancer statistics in China, 2015.CA Cancer J. Clin.201666211513210.3322/caac.2133826808342
    [Google Scholar]
  3. PelkonenM. LuostariK. TengströmM. AhonenH. BerdelB. KatajaV. SoiniY. KosmaV.M. MannermaaA. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival.BMC Cancer201515143110.1186/s12885‑015‑1440‑526014348
    [Google Scholar]
  4. PerouC.M. SørlieT. EisenM.B. van de RijnM. JeffreyS.S. ReesC.A. PollackJ.R. RossD.T. JohnsenH. AkslenL.A. FlugeØ. PergamenschikovA. WilliamsC. ZhuS.X. LønningP.E. Børresen-DaleA.L. BrownP.O. BotsteinD. Molecular portraits of human breast tumours.Nature2000406679774775210.1038/3502109310963602
    [Google Scholar]
  5. DingS. QuW. JiaoY. ZhangJ. ZhangC. DangS. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/beta-catenin signaling pathway. Cancer biomarkers: section.Dis. Markers2018
    [Google Scholar]
  6. BhandariA. XiaE. ZhouY. GuanY. XiangJ. KongL. WangY. YangF. WangO. ZhangX. ITGA7 functions as a tumor suppressor and regulates migration and invasion in breast cancer.Cancer Manag. Res.20181096997610.2147/CMAR.S16037929760566
    [Google Scholar]
  7. LiuJ. YeL. LiQ. WuX. WangB. OuyangY. YuanZ. LiJ. LinC. Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.J. Pathol.20182441718310.1002/path.499528991374
    [Google Scholar]
  8. GongZ. ZhangS. ZhangW. HuangH. LiQ. DengH. MaJ. ZhouM. XiangJ. WuM. LiX. XiongW. LiX. LiY. ZengZ. LiG. Long non-coding RNAs in cancer.Sci. China Life Sci.201255121120112410.1007/s11427‑012‑4413‑923233227
    [Google Scholar]
  9. ShiS.J. WangL.J. YuB. LiY.H. JinY. BaiX.Z. LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.Oncotarget2015613116521166310.18632/oncotarget.345725871474
    [Google Scholar]
  10. DongH. WangW. ChenR. ZhangY. ZouK. YeM. HeX. ZhangF. HanJ. Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer.Int. J. Oncol.20185331013102610.3892/ijo.2018.446730015837
    [Google Scholar]
  11. ZhongH. YangJ. ZhangB. WangX. PeiL. ZhangL. LinZ. WangY. WangC. LncRNA GACAT3 predicts poor prognosis and promotes cell proliferation in breast cancer through regulation of miR-497/CCND2. Cancer biomarkers: section.Dis. Markers2018
    [Google Scholar]
  12. YangH. ChenT. XuS. ZhangS. ZhangM. Long non-coding RNA FOXC2-AS1 predicts poor survival in breast cancer patients and promotes cell proliferation.Oncol. Res.2018
    [Google Scholar]
  13. WuH. HuY. LiuX. SongW. GongP. ZhangK. ChenZ. ZhouM. ShenX. QianY. FanH. LncRNA TRERNA1 function as an enhancer of SNAI1 promotes gastric cancer metastasis by regulating epithelial-mesenchymal transition.Mol. Ther. Nucleic Acids2017829129910.1016/j.omtn.2017.06.02128918030
    [Google Scholar]
  14. MillerC.R. RuppertA.S. FobareS. ChenT.L. LiuC. LehmanA. BlachlyJ.S. ZhangX. LucasD.M. GreverM.R. TallmanM.S. FlinnI.W. RassentiL.Z. KippsT.J. SampathD. CoombesK.R. HertleinE.K. The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.Oncotarget2017816259422595410.18632/oncotarget.1540128412730
    [Google Scholar]
  15. LivakK.J. SchmittgenT.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods200125440240810.1006/meth.2001.126211846609
    [Google Scholar]
  16. ThieryJ.P. SleemanJ.P. Complex networks orchestrate epithelial-mesenchymal transitions.Nat. Rev. Mol. Cell Biol.20067213114210.1038/nrm183516493418
    [Google Scholar]
  17. RunowiczC.D. LeachC.R. HenryN.L. HenryK.S. MackeyH.T. Cowens-AlvaradoR.L. CannadyR.S. Pratt-ChapmanM.L. EdgeS.B. JacobsL.A. HurriaA. MarksL.B. LaMonteS.J. WarnerE. LymanG.H. GanzP.A. American cancer society/american society of clinical oncology breast cancer survivorship care guideline.CA Cancer J. Clin.2016661437310.3322/caac.2131926641959
    [Google Scholar]
  18. HongW. DongE. The past, present and future of breast cancer research in China.Cancer Lett.201435111510.1016/j.canlet.2014.04.00724735750
    [Google Scholar]
  19. Cancer Genome AtlasN. Comprehensive molecular portraits of human breast tumours.Nature20124907418617010.1038/nature1141223000897
    [Google Scholar]
  20. YeX. HuangH. HuangW. HuW. LncRNA THOR promotes human renal cell carcinoma cell growth.Biochem. Biophys. Res. Commun.2018501366166710.1016/j.bbrc.2018.05.04029752937
    [Google Scholar]
  21. ZhouY. DaiW. WangH. PanH. WangQ. Long non-coding RNA CASP5 promotes the malignant phenotypes of human glioblastoma multiforme.Biochem. Biophys. Res. Commun.2018500496697210.1016/j.bbrc.2018.04.21729715460
    [Google Scholar]
  22. XiaE. BhandariA. ShenY. ZhouX. SindanN. XiangJ. GuanY. YangF. WangO. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.Biochem. Biophys. Res. Commun.2018496262863210.1016/j.bbrc.2018.01.10229366479
    [Google Scholar]
  23. HayE.D. An overview of epithelio-mesenchymal transformation.Cells Tissues Organs1995154182010.1159/0001477488714286
    [Google Scholar]
  24. ZhengJ. ZhaoS. HeX. ZhengZ. BaiW. DuanY. ChengS. WangJ. LiuX. ZhangG. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.Biochem. Biophys. Res. Commun.2016480450851410.1016/j.bbrc.2016.08.12027558961
    [Google Scholar]
  25. HouP. ZhaoY. LiZ. YaoR. MaM. GaoY. ZhaoL. ZhangY. HuangB. LuJ. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis.Cell Death Dis.201456e128710.1038/cddis.2014.24924922071
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673328556240813111417
Loading
/content/journals/cmc/10.2174/0109298673328556240813111417
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): Breast cancer; chemotherapy; invasion; LINC00651; migration; proliferation
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test